Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Huadong Medicine Co., Ltd
  6. Summary
    000963   CNE0000011S1

HUADONG MEDICINE CO., LTD

(000963)
  Report
End-of-day quote. End-of-day quote Shenzhen Stock Exchange - 05/14
47.77 CNY   -1.10%
2020HUADONG MEDICINE CO., LTD  : 3rd quarter report
CO
2020HUADONG MEDICINE CO., LTD  : Half-year report
CO
2020HUADONG MEDICINE CO., LTD  : 1st quarter report
CO
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
05/10/2021 05/11/2021 05/12/2021 05/13/2021 05/14/2021 Date
44.39 45.41 47.41 48.3 47.77 Last
73764010 93173020 86118300 83771720 62429820 Volume
+1.86% +2.30% +4.40% +1.88% -1.10% Change
Financials
Sales 2021 36 421 M 5 658 M 5 658 M
Net income 2021 2 935 M 456 M 456 M
Net cash position 2021 3 947 M 613 M 613 M
P/E ratio 2021 28,5x
Yield 2021 0,50%
Sales 2022 41 297 M 6 416 M 6 416 M
Net income 2022 3 563 M 554 M 554 M
Net cash position 2022 6 336 M 984 M 984 M
P/E ratio 2022 23,5x
Yield 2022 1,07%
Capitalization 83 588 M 12 985 M 12 986 M
EV / Sales 2021 2,19x
EV / Sales 2022 1,87x
Nbr of Employees 11 359
Free-Float 41,9%
More Financials
Company
Huadong Medicine Co., Ltd. specializes in the development, manufacture and marketing of medical products and vaccines. The products are intended primarily for the treatment of tumors, immune disorders, endocrine disorders, orthopedic and traumatological disorders, digestive system diseases and viral diseases. 
Sector
Drug Retailers
Calendar
05/21 | 02:00amShareholder meeting
More about the company
Notations Surperformance© of Huadong Medicine Co., Ltd
Trading Rating : Investor Rating :
More Ratings
All news about HUADONG MEDICINE CO., LTD
2020HUADONG MEDICINE CO., LTD  : 3rd quarter report
CO
2020HUADONG MEDICINE CO., LTD  : Half-year report
CO
2020HUADONG MEDICINE CO., LTD  : 1st quarter report
CO
2020HUADONG MEDICINE CO., LTD  : 1st quarter report
CO
2019HUADONG MEDICINE CO., LTD  : Annual Report
CO
2018HUADONG MEDICINE  : Sinclair Pharma agrees to potential offer from China's Huado..
RE
2018HUADONG MEDICINE  : Sinclair Pharma says Chinese firms given more time to make t..
RE
2018Britain's Sinclair Pharma gets takeover interest from Chinese firms, shares s..
RE
More news
News in other languages on HUADONG MEDICINE CO., LTD

- No features available -

More news
Chart HUADONG MEDICINE CO., LTD
Duration : Period :
Huadong Medicine Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HUADONG MEDICINE CO., LTD
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Average target price 39,13 CNY
Last Close Price 47,77 CNY
Spread / Highest target 18,1%
Spread / Average Target -18,1%
Spread / Lowest Target -57,1%
EPS Revisions
Managers and Directors
NameTitle
Liang Lü General Manager & Director
Hong Lan Ma Chief Financial Officer
Bang Liang Li Chairman
Xin Hua Bai Chairman-Supervisory Board
Lan Yang Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
HUADONG MEDICINE CO., LTD79.86%12 985
WALGREENS BOOTS ALLIANCE, INC.35.76%47 291
JD HEALTH INTERNATIONAL INC.-28.87%43 749
MCKESSON CORPORATION12.12%30 846
CARDINAL HEALTH, INC.4.74%16 347
SINOPHARM GROUP CO., LTD.35.74%10 287